ORAL SEMAGLUTIDE

78023 reported adverse events

Drug classes: GLP-1 Receptor Agonist [EPC]

These side effects are most commonly reported by patients taking ORAL SEMAGLUTIDE:

# Side effect Count
0 NAUSEA 11150
1 OFF LABEL USE 7890
2 VOMITING 7332
3 DIARRHOEA 6833
4 DECREASED APPETITE 5107
5 CONSTIPATION 4976
6 WEIGHT DECREASED 4777
7 IMPAIRED GASTRIC EMPTYING 4175
8 PRODUCT USE IN UNAPPROVED INDICATION 3761
9 BLOOD GLUCOSE INCREASED 3460
See all common reactions for ORAL SEMAGLUTIDE

ORAL SEMAGLUTIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYCLIC VOMITING SYNDROME 447 0.6107
1 IMPAIRED GASTRIC EMPTYING 4175 0.3060
2 GASTRIC HYPOMOTILITY 88 0.2866
3 CORRECTIVE LENS USER 242 0.2485
4 GASTROINTESTINAL HYPOMOTILITY 511 0.2265
5 OPTIC ISCHAEMIC NEUROPATHY 838 0.2163
6 PRODUCT DOSE CONFUSION 73 0.2056
7 MEDULLARY THYROID CANCER 63 0.1853
8 DRUG DOSE TITRATION NOT PERFORMED 233 0.1271
9 METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS 32 0.1260
See all enriched reactions for ORAL SEMAGLUTIDE